Literature DB >> 1597543

Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus.

P Saiag1, E Caumes, O Chosidow, J Revuz, J C Roujeau.   

Abstract

BACKGROUND: Although patients infected with the human immunodeficiency virus (HIV) are predisposed to cutaneous adverse drug reactions, only a few cases of toxic epidermal necrolysis (TEN) have been reported in this setting.
OBJECTIVE: Our purpose was to examine the features of TEN in HIV-infected patients.
METHODS: We performed a retrospective analysis of all HIV-infected patients in a series of 80 consecutive cases of TEN during a 6-year period.
RESULTS: Fourteen patients were HIV infected. They had typical TEN, with epidermal detachment involving 20.6% +/- 8.0% of the skin surface. Suspected drugs were sulfadiazine, trimethoprim-sulfamethoxazole, sulfadoxine, clindamycin, phenobarbital, and chlormezanone. Patients with the acquired immunodeficiency syndrome (AIDS) exhibit a dramatically increased risk of TEN. During our study period 15 cases of AIDS-associated TEN occurred in the greater Paris area, whereas 0.04 case would have been expected if the incidence of TEN were the same in these patients as in the general population.
CONCLUSION: HIV-infected patients, especially those with AIDS, may develop TEN that shares many similarities with the disease in immunocompetent patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597543     DOI: 10.1016/0190-9622(92)70082-q

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  17 in total

1.  Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity.

Authors:  D J Naisbitt; S J Hough; H J Gill; M Pirmohamed; N R Kitteringham; B K Park
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

2.  Toxic epidermal necrolysis in a patient suffering from acquired immune deficiency syndrome.

Authors:  S Alfandari; C Beuscart; E Delaporte; E Senneville; Y Mouton
Journal:  Infection       Date:  1994 Sep-Oct       Impact factor: 3.553

3.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

4.  The Treatment of Lyell'S Syndrome: our Experience.

Authors:  B Napoli; N D'Arpa; M Masellis
Journal:  Ann Burns Fire Disasters       Date:  2006-03-31

Review 5.  Drug-induced severe skin reactions. Incidence, management and prevention.

Authors:  P Wolkenstein; J Revuz
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

Review 6.  Drug-induced skin, nail and hair disorders.

Authors:  Laurence Valeyrie-Allanore; Bruno Sassolas; Jean-Claude Roujeau
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

7.  IVIG and under Burn Unit Care Yield Favorable Outcomes in Pediatric Patients with Toxic Epidermal Necrolysis: A Case Report and Literature Review.

Authors:  Tareq Z Alzughayyar; Wasim Noureddin Ibrahim Hamad; Eman A S Abuqweider; Bilal Nabeel Mohammad Alqam; Sadi A Abukhalaf; Rami A Misk; Fawzy M Abunejma; Jihad Samer Zalloum; Mohanad Saleh; Ali A Abumunshar; Yousef I M Zatari
Journal:  Case Rep Dermatol Med       Date:  2020-01-30

Review 8.  Allergic emergencies encountered by the dermatologist. Severe cutaneous adverse drug reactions.

Authors:  P Wolkenstein; J Revuz
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 10.817

9.  A rare case of toxic epidermal necrolysis with unexpected Fever resulting from dengue virus.

Authors:  Gerrit Grieb; Mastoura Alazemi; Rituparna Das; Sebastian E Dunda; Paul C Fuchs; Norbert Pallua
Journal:  Case Rep Dermatol       Date:  2010-12-07

10.  Antiretroviral Therapy-associated Serious and Life-threatening Toxicities.

Authors:  Alice K. Pau
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.